The Wilcoxon signed-rank test and logistic regression analysis were performed to evaluate the relationship between ADAM12 gene expression and clinicopathological variables in patients with hepatocellular carcinoma. This evidence concerns the gene ADAM12 and hepatocellular carcinoma.